$ABCL

$12.56 +$0.48 (3.97%) Live

$ABCL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 306.6M shares outstanding

Who owns ABCL?

By type of holder

Institutions 37.9% Insiders 56.5% Everyone else 5.7%

Concentration Top 10 holders own 82.1%

Hansen Carl L. G. 36.7% · Thermopylae Holdings Ltd. 18.3%

Institutional ownership

37.9%

-2.7 pts vs last qtr

Institutional holders

148

+11 vs last qtr

Net shares bought

−8.2M

by institutions in Q2 2026

New / sold out

39 / 28

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Bank Of America Corp /de/ +3.1M
Baker Bros. Advisors LP +2.7M

Biggest sellers in Q2 2026

Goldman Sachs Group Inc −3.5M
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC −3.3M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for AbCellera Biologics Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+97.4%

+12.00% a year

Each share's claim on the business

−49.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $277M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years52% 3–5 years13% 1–3 years18% Under 1 year16%

Quarterly turnover

16.9%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting ABCL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BB Baker Bros. Advisors LP	33.0M	10.77%	+2.7M (+9.0%)	≤2021	1.3%
Shares held by quarter Peak holding33.0M (Q2'26) Change over 8 quarters+5.5M Share of the company10.770% Baker Bros. Advisors LP's full portfolio →
CW Capital World Investors	13.6M	4.43%	+227.3K (+1.7%)	2024	0.0%
Shares held by quarter Peak holding13.6M (Q2'26) Change over 8 quarters+13.6M Share of the company4.430% Capital World Investors's full portfolio →

Baker Bros. Advisors LP

33.0M

% of company

10.77%

Change vs last qtr

+2.7M (+9.0%)

Held since

≤2021

Capital World Investors

13.6M

% of company

4.43%

Change vs last qtr

+227.3K (+1.7%)

Held since

2024

28 more super investors behind a free account

See every manager holding AbCellera Biologics Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ABCL on Form N-PORT; together they hold 7.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SW SMALLCAP World Fund Inc SMALLCAP World Fund Inc	$104M	13.2M	4.31%	0.11%	June 30, 2026
BH BlackRock Health Sciences Opportunities Portfolio BlackRock Funds	$14.4M	1.3M	0.41%	0.23%	August 31, 2026

SMALLCAP World Fund Inc

Position value

$104M

% of company

4.31%

% of the fund

0.11%

As of

June 30, 2026

BlackRock Health Sciences Opportunities Portfolio

BlackRock Funds

Position value

$14.4M

% of company

0.41%

% of the fund

0.23%

As of

August 31, 2026

23 more funds behind a free account

See every fund holding AbCellera Biologics Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
HC Hansen Carl L. G. Insider	112.6M	36.73%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company36.730% Hansen Carl L. G.'s insider activity →
TH Thermopylae Holdings Ltd. Insider	56.1M	18.31%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company18.310% Thermopylae Holdings Ltd.'s insider activity →

Hansen Carl L. G.

Insider

112.6M

% of company

36.73%

Change vs last qtr

—

Held since

—

Thermopylae Holdings Ltd.

Insider

56.1M

% of company

18.31%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of AbCellera Biologics Inc..

Comments